Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 189 entries
View as:

An Evaluation of a Cytomegalovirus (CMV) Vaccine (ASP0113) in CMV-Seropositive and CMV-Seronegative Healthy Subjects and CMV-Seronegative Dialysis Patients

Phase: N/A Priority: Normal
NCT ID: NCT02103426 Org: User:
Start: 12/30/13 End: 05/10/16 Due: 05/10/17

A Study to Investigate the Absorption, Metabolism and Excretion of [14C]ASP8273 in Subjects With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT02674555 Org: User:
Start: 11/15/16 End: 11/15/16 Due: 11/15/17

Drug Interaction Study of Multiple Doses of Isavuconazole and a Single Dose of Bupropion

Phase: N/A Priority: Normal
NCT ID: NCT01635972 Org: User:
Start: 06/30/12 End: 07/31/12 Due: 07/31/13

A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04729114 Org: User:
Start: 06/14/21 End: 05/31/29 Due: 05/31/30

A Study of an Intratumoral Oncolytic Virus in Patients With Advanced Metastatic Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT03954067 Org: User:
Start: 09/03/19 End: 04/19/24 Due: 04/19/25

A Study to Evaluate a Single Intravenous (IV) Dose Using a New Manufactured Clone and Single Ascending Doses of Subcutaneous (SC) Injections

Phase: N/A Priority: Normal
NCT ID: NCT02150070 Org: User:
Start: 08/31/11 End: 06/30/12 Due: 06/30/13

A Study to Assess Potential Interaction Between ASP8062 and Alcohol in Healthy Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT04003402 Org: User:
Start: 07/16/19 End: 10/16/19 Due: 10/16/20

Drug Interaction Study of Isavuconazole and Warfarin in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01657825 Org: User:
Start: 06/30/12 End: 07/31/12 Due: 07/31/13

A Study of ASP2074 in Adults With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT05646797 Org: User:
Start: 02/28/23 End: 10/17/24 Due: 10/17/25

A Study to Assess the Relative Bioavailability Between Two ASP015K Tablets and the Food Effect of a New Tablet in Healthy Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01929577 Org: User:
Start: 05/31/13 End: 08/31/13 Due: 08/31/14

Avacincaptad Pegol Open-Label Extension for Patients With Geographic Atrophy

Phase: N/A Priority: Normal
NCT ID: NCT05536297 Org: User:
Start: 09/26/22 End: 04/10/25 Due: 04/10/26

A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Escalating Doses of AGS67E Given as Monotherapy in Subjects With Refractory or Relapsed Lymphoid Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT02175433 Org: User:
Start: 10/14/14 End: 10/29/19 Due: 10/29/20

A Study to Determine Safety and Tolerability of Enzalutamide (MDV3100) in Combination With Abiraterone Acetate in Bone Metastatic Castration-Resistant Prostate Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT01650194 Org: User:
Start: 07/09/12 End: 01/04/18 Due: 01/04/19

Study to Assess Analgesic Efficacy and Safety of ASP3662 in Subjects With Painful Diabetic Peripheral Neuropathy

Phase: N/A Priority: Normal
NCT ID: NCT02372578 Org: User:
Start: 05/27/15 End: 05/20/16 Due: 05/20/17

A Study to Assess ASP2713 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT04017208 Org: User:
Start: 07/31/19 End: 08/31/20 Due: 08/31/21

A Study to Investigate the Effect of Mild and Moderate Hepatic Impairment on the Safety and Tolerability of Fezolinetant Compared to Participants With Normal Hepatic Function

Phase: N/A Priority: Normal
NCT ID: NCT04482270 Org: User:
Start: 09/02/20 End: 03/22/21 Due: 03/22/22

Study to Evaluate the Pharmacokinetics of 14C-labeled Isavuconazole Following a Single Oral Dose of 14C-labeled Prodrug Isavuconazonium Sulfate (BAL8557) in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01813461 Org: User:
Start: 10/31/12 End: 11/30/12 Due: 11/30/13

A Study to Evaluate the Effects of ASP5502 in Healthy Adults and Adults With Primary Sjögren's Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT06544642 Org: User:
Start: 08/21/24 End: 07/31/27 Due: 07/31/28

A Study Following Women in Menopause Treated With a Non-hormonal Therapy for Hot Flashes and Night Sweats

Phase: N/A Priority: Normal
NCT ID: NCT06049797 Org: User:
Start: 11/15/23 End: 11/30/26 Due: 11/30/27

A Study to Find Out if Fezolinetant Helps Reduce Moderate to Severe Hot Flashes in Women Going Through Menopause

Phase: N/A Priority: Normal
NCT ID: NCT04003155 Org: User:
Start: 07/11/19 End: 08/11/21 Due: 08/11/22

A Study of AGS-16C3F vs. Axitinib in Metastatic Renal Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT02639182 Org: User:
Start: 05/03/16 End: 10/02/20 Due: 10/02/21

Safety and Activity of IMAB362 in Combination With Zoledronic Acid and Interleukin-2 in CLDN18.2-positive Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01671774 Org: User:
Start: 10/16/12 End: 10/13/14 Due: 10/13/15

A Study to Assess the Effect of CK-2127107 on Physical Function in Subjects With Chronic Obstructive Pulmonary Disease

Phase: N/A Priority: Normal
NCT ID: NCT02662582 Org: User:
Start: 06/30/16 End: 06/08/18 Due: 06/08/19

A Study to Evaluate the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of a Single Dose of Sirolimus in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01809860 Org: User:
Start: 11/30/11 End: 01/31/12 Due: 01/31/13

A Dose-ranging Study of the Efficacy of ESN364 in Postmenopausal Women Suffering Vasomotor Symptoms (Hot Flashes)

Phase: N/A Priority: Normal
NCT ID: NCT03192176 Org: User:
Start: 07/19/17 End: 09/19/18 Due: 09/19/19